Skip to content

Cognitive function in hemodialysis patients

The impact of inflammation and Autonomic Nervous System activity on cognitive impairment during a hemodialysis session

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12616000776404
Acronym
ConFun
Enrollment
15
Registered
2016-06-14
Start date
2016-04-25
Completion date
2016-05-07
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Patients with CKD experience many clinical complications and accordingly these complications affect the function of all organ systems of the human body. Cognitive dysfunction and dementia is a common complication found in CKD patients which is profound even in the early stages. Many studies have demonstrated that CKD patients at all stages but especially those in ESRD are at high risk for cognitive dysfunction development and dementia. Indeed, it has been estimated that the prevalence of cognitive impairment in HD patients is around 30-60%. Reaction time, mental speed, verbal memory, focused concentration; visual scanning and choice reaction time are components of cognitive function, which usually in CKD patients are progressively reduced. Furthermore, inflammation, which is increased in CKD patients and Autonomic Nervous System (ANS) dysfunction, seems to contribute to cognitive impairment in HD patients. It has been supported that inflammation may have a role in the aetiology of mild cognitive impairment. Except from inflammation, there is evidence that ANS dysfunction is associated with mild cognitive function.Thus, the aim of this study was to investigate the impact of inflammation and ANS activity on cognitive function during a HD session.

Interventions

We investigate the effects of inflammation and Autonomic Nervous System activity on cognitive function during a hemodialysis session.All measurements took place 30 min before the onset of the HD therapy and 30 min after the HD therapy. Subjects were studied in a quiet, comfortable room with controlled temperature between 25 and 28 degrees Celcius. Inflammation was evaluated ANS function was assessed simultaneously using pupillometric and Heart Rate Variability (HRV) measurements. A physiologist

We investigate the effects of inflammation and Autonomic Nervous System activity on cognitive function during a hemodialysis session.All measurements took place 30 min before the onset of the HD therapy and 30 min after the HD therapy. Subjects were studied in a quiet, comfortable room with controlled temperature between 25 and 28 degrees Celcius. Inflammation was evaluated ANS function was assessed simultaneously using pupillometric and Heart Rate Variability (HRV) measurements. A physiologist administered all the methods. Cognitive function assessment Cognitive function was assessed before the onset of the HD therapy and 30 min after the completion of the HD therapy. Mini-Mental State Examination (MMSE) in Greek, which includes 11 items and needs about 7-10 minutes to complete, was used for the cognitive impairment evaluation. MMSE evaluates orientation, attention, memory, concentration, language and constructional ability, with a total score range from 0 to 30 which reflects the number of correct responses . Score from 30 to 24 indicates normal cognitive function while score below 24 reflects cognitive impairment, which could be mild (score between 19-24), moderate (score between 10-18) or severe (score below or equal to 9). Pupillometry The hand-held infrared pupillometer (NeurOptics PLR-200 trademark City and Country) was used to measure the pupil size and the pupillary light reflex. The pupillometer uses infrared imaging technology and it requires no calibration by the user. Pupillometry was performed on each eye separately. Each eye assessed three times with 5 minutes apart. The pupillometric indices were: 1) maximum pupil size namely the baseline pupil diameter after 2 min dark adaptation, which is an indicator of symaptho-vagal balance, 2) minimum pupil size, which is generally defined as a marker of sympatho-vagal balance, since it is involved in the second segment of the V-shaped pupillometric response, 3) constriction, which is modulated by PNS activity, 4) latency, which is an index of sympatho-vagal balance, 5) average constriction velocity and 6) maximum constriction velocity, which are both sensitive indices of PNS activity , 7) average dilation velocity, which reflects sympatho-vagal balance and 8) 75% pupil size recovery time, which is an index of SNS activity. An average of the three measurements was recorded as the final value. Inflammation status The blood samples were collected 30 min before the onset of the HD therapy and 30 min after the completion of the HD therapy. The blood samples were collected in tubes containing EDTA and centrifuged immediately. Serum C-reactive protein (CRP) was detected using the immunonephelometric assay on the BNII nephelometer (N High Sensitivity CRP; Dade Behring Inc, Deerfield, IL).

Sponsors

Aristotle University of Thessaloniki
Lead SponsorUniversity

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

Aged 20 to 60 inclusive, all participants must have been diagnosed with kidney disease and being on HD therapy for 4 hours, 3 times/week for at least six month.

Exclusion criteria

Patients excluded from the study if they had any of the following criteria: unstable hypertension, congestive heart failure (grade > II according to NYHA), cardiac arrhythmias, anemia, recent myocardial infarction, unstable angina, diabetes mellitus, active liver disease or previous established cause of syncope. Moreover, patients with medications that may affect the cardiovascular or ANS system or pupillary light reflex were excluded from the study.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026